STEELE GLENN JR MD PHD 4
4 · PTC THERAPEUTICS, INC. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
STEELE GLENN JR MD PHD
Director
Transactions
- Exercise/Conversion
Common Stock
2026-01-02$30.86/sh+12,000$370,320→ 30,500 total - Sale
Common Stock
2026-01-02$76.35/sh−12,000$916,200→ 18,500 total - Award
Common Stock
2026-01-02+4,000→ 22,500 total - Exercise/Conversion
Stock Option (Right to Buy)
2026-01-02−12,000→ 0 totalExercise: $30.86Exp: 2026-01-03→ Common Stock (12,000 underlying) - Award
Stock Option (Right to Buy)
2026-01-02+3,475→ 3,475 totalExercise: $76.74Exp: 2036-01-01→ Common Stock (3,475 underlying)
Footnotes (4)
- [F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 8, 2025.
- [F2]Restricted stock units granted on January 2, 2026 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 2, 2026 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 2, 2027.
- [F3]Currently exercisable.
- [F4]This option was granted on January 2, 2026 and vests over one year in twelve equal monthly installments, commencing on February 2, 2026.